| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.28 | 0.07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.07 |